Stock Scorecard
Stock Summary for West Pharmaceutical Services Inc (WST) - $375.99 as of 9/24/2026 6:16:34 PM EST
Total Score
15 out of 30
Safety Score
50 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for WST
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for WST
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for WST
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for WST
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for WST (50 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for WST
Financial Details for WST
Company Overview |
|
|---|---|
| Ticker | WST |
| Company Name | West Pharmaceutical Services Inc |
| Country | N/A |
| Description | West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL INSTRUMENTS & SUPPLIES |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | 10/22/2026 |
Stock Price History |
|
| Last Day Price | 375.99 |
| Price 4 Years Ago | 232.94 |
| Last Day Price Updated | 9/24/2026 6:16:34 PM EST |
| Last Day Volume | 876,987 |
| Average Daily Volume | 559,132 |
| 52-Week High | 385.75 |
| 52-Week Low | 223.52 |
| Last Price to 52 Week Low | 68.21% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 56.27 |
| Sector PE | 49.58 |
| 5-Year Average PE | 47.21 |
| Free Cash Flow Ratio | 60.74 |
| Industry Free Cash Flow Ratio | 25.70 |
| Sector Free Cash Flow Ratio | 32.48 |
| Current Ratio Most Recent Quarter | 2.82 |
| Total Cash Per Share | 6.19 |
| Book Value Per Share Most Recent Quarter | 42.47 |
| Price to Book Ratio | 8.53 |
| Industry Price to Book Ratio | 3.20 |
| Sector Price to Book Ratio | 27.37 |
| Price to Sales Ratio Twelve Trailing Months | 7.65 |
| Industry Price to Sales Ratio Twelve Trailing Months | 121.03 |
| Sector Price to Sales Ratio Twelve Trailing Months | 32.60 |
| Analyst Buy Ratings | 11 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 70,376,000 |
| Market Capitalization | 26,460,672,240 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 7/29/2026 |
| Previous Dividend Amount | 0.2200 |
| Current Dividend Amount | 0.2200 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 0.88 |
| Trailing Annual Dividend Yield | 0.24% |
| Forward Annual Dividend Rate | 0.88 |
| Forward Annual Dividend Yield | 0.24% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.31% |
| 5-Year Average Dividend Yield | 0.27% |
| 1-Year Dividend Growth Rate Percentage | 3.53% |
| 3-Year Dividend Growth Rate Percentage | 1.75% |
| 5-Year Dividend Growth Rate Percentage | 4.78% |
| All-Time Dividend Growth Rate Percentage | 7.02% |
| Dividend Payout Ratio | 11.24% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 18.10% |
| Annual Earnings Growth | 0.20% |
| Reported EPS 12 Trailing Months | 7.83 |
| Reported EPS Past Year | 4.50 |
| Reported EPS Prior Year | 7.29 |
| Net Income Twelve Trailing Months | 564,900,000 |
| Net Income Past Year | 493,700,000 |
| Net Income Prior Year | 492,700,000 |
| Quarterly Revenue Growth YOY | 13.80% |
| 5-Year Revenue Growth | 7.44% |
| Operating Margin Twelve Trailing Months | 22.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 435,800,000 |
| Total Cash Past Year | 791,300,000 |
| Total Cash Prior Year | 484,600,000 |
| Net Cash Position Most Recent Quarter | 232,900,000 |
| Net Cash Position Past Year | 588,500,000 |
| Long Term Debt Past Year | 202,800,000 |
| Long Term Debt Prior Year | 202,600,000 |
| Total Debt Most Recent Quarter | 202,900,000 |
| Equity to Debt Ratio Past Year | 0.94 |
| Equity to Debt Ratio Most Recent Quarter | 0.94 |
| Total Stockholder Equity Past Year | 3,176,000,000 |
| Total Stockholder Equity Prior Year | 2,682,300,000 |
| Total Stockholder Equity Most Recent Quarter | 2,990,200,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 436,900,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 6.21 |
| Free Cash Flow Past Year | 468,900,000 |
| Free Cash Flow Prior Year | 276,400,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 6.81 |
| MACD Signal | 3.46 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 1.14 |
| RSI | 69.40 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 9/24/2026 10:35:40 AM EST |